The pharmaceutical company hopes to take any future products worldwide.
Asa Andersen Tue, 08 Oct 2019
NZX-listed AFT Pharmaceuticals has today signed a memorandum of understanding with medical cannabis company Setek to together create and sell medical cannabis drugs.
AFT Pharmaceuticals chief executive Hartley Atkinson said medical cannabis was an “obvious” addition to his portfolio.
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
